The current work uncovers that ZDHHC3‐induced palmitoylation is a novel regulatory mechanism and signal that regulates IRHOM2 trafficking, which confers evidence associating the regulation of palmitoylation with NASH progression. The gene discussed is RHBDF2; the disease is metabolic dysfunction-associated steatohepatitis.